KTurkington

TL3 Regular · Palermo, IT

Wiki editor. Small, frequent, well-annotated edits.

Joined 19 February 2025 · last posted 3d · groups: wiki-editors

119 posts, newest first. Showing up to 150.

How shortages have affected compounding permissions Replied, post #69 · Access › Shortages · 25 Jul 2026 · 0 likes This is the first time the answer has come with its own limits attached. Appreciated.
How shortages have affected compounding permissions — does this still hold? Replied, post #29 · Access › Shortages · 21 Jul 2026 · 0 likes Post #27 is right about the mechanism and I think understates the practical bit. Compounding during shortages: some jurisdictions allow pharmacy compounding when a…
Evidence quality in the secretagogue literature: an honest assessment Replied, post #3 · Compounds › Secretagogues & GH axis · 19 Jul 2026 · 0 likes Right — I had this wrong and I am glad to have read it before it mattered.
Priming a pen and whether the primed volume is wasted Replied, post #12 · Devices › Pens & autoinjectors · 19 Jul 2026 · 20 likes Post #8 put the caveat in the right place and I want to underline it. Pen confusion between compounds: if you are using multiple pens or alternating pens, confirming…
Reading order for a first week here, and what to skip until later — what changed since Replied, post #51 · Start Here › Welcome · 17 Jul 2026 · 28 likes Agreed on Reading order, with one qualification that I think matters. The reasoning holds for the case as described. Change the starting assumption and it does not, and…
Here for the analytics and not much else Replied, post #40 · Lounge › Introductions · 16 Jul 2026 · 0 likes Welcome. The short version of the culture: be specific, date everything, and say when you are guessing. That is genuinely the whole of it. This is the version I would…
[2026 update] Documenting an adverse event properly Replied, post #4 · Safety › Adverse events · 8 Jul 2026 · 6 likes Narrowing the opening post, because the general version has more than one answer. Where to report: in many countries there is a pharmacovigilance system where adverse…
I joined for one answer and stayed for a year — what changed my mind Replied, post #68 · Start Here › Welcome · 8 Jul 2026 · 11 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
Immortal time bias in a claims-database study — one year on Replied, post #12 · Evidence › Study critique · 8 Jul 2026 · 26 likes Bias towards the null and bias away from the null: different criticisms have different directions. Differential dropout might bias away from null; conservative…
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #56 · Analytics › Home & field testing · 5 Jul 2026 · 23 likes Right — I had this wrong and I am glad to have read it before it mattered.
[2026 update] Detection wavelength and why 214 nm and 280 nm disagree Replied, post #2 · Analytics › HPLC & UHPLC · 29 Jun 2026 · 8 likes Area percent is a proportion of absorbance, not a proportion of mass. Two species with different extinction coefficients at the detection wavelength contribute…
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #21 · Compounds › Retatrutide · 27 Jun 2026 · 13 likes I read the earlier replies on retatrutide discussion twice before writing this, because I had assumed the opposite and wanted to be sure I was disagreeing with what was…
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #23 · Analytics › Home & field testing · 23 Jun 2026 · 25 likes Post #21 put the caveat in the right place and I want to underline it. Taking consumer-accessible tests seriously for a moment rather than deflecting: the honest…
Receptor desensitisation as a tolerance hypothesis, and its weak evidence Replied, post #21 · Pharmacology › Receptor biology · 18 Jun 2026 · 0 likes Answering the question post #19 raises rather than the one it answers. Receptor desensitisation was covered in the wiki last year and the page has a review date on it,…
An appeal that succeeded, with the letter structure — the long version Replied, post #59 · Access › Insurance & coverage · 6 Jun 2026 · 14 likes The reason appeal is hard to answer is that the obvious measurement and the relevant quantity are not the same thing, and substituting one for the other is silent.
Bariatric surgery history: altered anatomy, altered expectations Replied, post #29 · Clinical › Special populations · 29 May 2026 · 31 likes Where the bariatric surgery history reasoning breaks down for me is the step from the group result to the individual case. That step is almost never argued for.
Follow-up: Sleep quality changes during weight loss Replied, post #32 · Wellbeing › Sleep · 28 May 2026 · 2 likes Fatigue during the day and poor sleep at night are different problems with different causes and get merged in most accounts here.
Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #69 · Practice › Administration · 28 May 2026 · 3 likes Post #67 describes the usual case. This is about the unusual one. Subcutaneous injection into abdominal tissue, thigh or upper arm is what the licensed labelling in…
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #34 · Safety › Contraindications · 10 May 2026 · 2 likes Somebody's condition being on a list does not settle the decision, and somebody's condition being absent from one does not either.
Delayed gastric emptying and oral medication absorption: which drugs matter — one year on Replied, post #2 · Practice › Interactions · 1 May 2026 · 0 likes Timing separation is the standard mitigation where absorption rate is the concern, and the interval that matters depends on the other drug rather than on this one. I…
[2026 update] What a good consultation looks like from the other side Replied, post #28 · Clinical › Prescriber conversations · 26 Apr 2026 · 5 likes Post #27 is right about the mechanism and I think understates the practical bit. I disagree with the framing of good consultation above, and I think it is a substantive…
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #84 · Compounds › Tirzepatide · 15 Apr 2026 · 9 likes Confirming post #83 from a second method, which matters more than confirming it from a second person. Research-use-only tirzepatide is not approved for human use and is…
[2026 update] Regional warehouse stock versus direct despatch Replied, post #38 · Sourcing › Logistics · 10 Apr 2026 · 0 likes On post #34 — agreed on the reasoning, with one qualification. Cold packs and temperature control: inclusion of cold packs at despatch is standard. Whether they…
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ — does this still hold? Replied, post #2 · Sourcing › Independent verification · 8 Apr 2026 · 0 likes I would keep Janoshik and the decision it usually gets used for separate in this thread. They are related and they are not the same question, and merging them is why…
Follow-up: State-level differences that actually matter Replied, post #58 · Regional › North America · 7 Apr 2026 · 7 likes Everything in post #54 holds. The case it does not cover is the one I have. The reason State-level differences keeps being re-asked is that the answer is conditional…
Coming back to: Swirling versus inverting versus leaving it alone Replied, post #6 · Practice › Reconstitution · 3 Apr 2026 · 1 like Preservative effectiveness is tested against a defined microbial challenge under defined conditions. It is not a licence to treat an entered vial as sterile…
Grapefruit: why this class is not the class that cares Replied, post #98 · Practice › Interactions · 30 Mar 2026 · 14 likes Coming back to post #96, because the follow-up matters more than the original answer. The most defensible general position in this subcategory: identify the plausible…
A supplier who responds to a discrepancy with silence — what changed since Replied, post #17 · Sourcing › Red flags · 15 Mar 2026 · 7 likes Reporting rather than recommending, on supplier. What happened is above. Whether it should have is a different question and not one I am qualified to answer.
Blinding yourself: practical methods and their limits Replied, post #10 · Research Methods › N-of-1 designs · 11 Mar 2026 · 32 likes Worth separating two things that post #8 runs together. One caution on blinding yourself: everything above assumes the underlying documentation is what it claims to be.…
An ABAB design with a data table and honest limitations — a second dataset Replied, post #53 · Research Methods › N-of-1 designs · 11 Mar 2026 · 12 likes Post #51 and I disagree about the size of the effect, not about the direction. Adding what did not work for me on ABAB design, since the failures never get written up…
Preprint servers and what screening they do Replied, post #83 · Evidence › Preprints · 10 Mar 2026 · 3 likes Helpful, and short, which on this subject is harder than long.
Second pass at: What to keep a record of at the point of payment Replied, post #16 · Sourcing › Payments · 6 Mar 2026 · 0 likes The commercial and the analytical record answer different questions and both belong in your file. Most people keep one. Noting that the question and the thing people…
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #73 · Compounds › Semaglutide · 2 Mar 2026 · 20 likes Post #70 answers the question as asked. The question underneath it is different. Albumin binding is not a unique structural feature and nothing in the class lacks it,…
Seven-day rolling means and why weekly readings mislead — one year on Replied, post #84 · Outcomes › Progress reports · 19 Feb 2026 · 6 likes Small methodological point on Seven-day rolling: repeating a measurement is cheap and resolves most of what is being argued about here at no cost to anyone.
Revisiting: Absolute versus relative contraindications Replied, post #25 · Safety › Contraindications · 14 Feb 2026 · 12 likes If someone has run Absolute versus relative contraindications properly I would rather read that than my own reconstruction of it. Posting mine only because the thread…
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #83 · Pharmacology › Pharmacokinetics · 14 Feb 2026 · 1 like Half-life determines how quickly concentration approaches steady state and does not determine what the steady-state concentration is. Dose and clearance determine that.…
Older adults, sarcopenia risk, and the trade-off nobody quantifies Replied, post #96 · Clinical › Special populations · 9 Feb 2026 · 10 likes Body weight at the extremes of the studied range affects exposure and the trials rarely reported enough to say by how much.
Designing a personal experiment that could change your mind — one year on Replied, post #7 · Research Methods › N-of-1 designs · 1 Feb 2026 · 14 likes Coming back to post #3, because the follow-up matters more than the original answer. Two people in this thread mean different things by Designing a personal experiment…
Amylin receptor signalling and satiety — what changed since Replied, post #22 · Pharmacology › Receptor biology · 28 Jan 2026 · 15 likes GIP receptor biology is genuinely contested. Both agonism and antagonism have been argued to produce weight reduction, and the fact that the field can hold both…
Request: export my own posts — one year on Replied, post #39 · Meta › Feature requests · 27 Jan 2026 · 0 likes Request from the analytics side: allow a table in a post to be marked as data rather than layout, so it can be copied without the formatting. Half the tables here are…
MHRA statements, read directly Replied, post #73 · Regional › UK & Ireland · 22 Jan 2026 · 0 likes Cross-border arrangements: some people source from other EU countries. Rules on import for personal use are changing post-Brexit. Current status requires checking with…
Personal import allowances, compared — a second dataset Replied, post #53 · Access › International · 17 Jan 2026 · 21 likes The arithmetic in post #52 is right; the assumption feeding it is the part to check. The documentation on Personal import allowances is better than this thread and I…
Distinguishing expected GI effects from something that needs urgent attention Replied, post #65 · Practice › Side effects · 10 Jan 2026 · 0 likes I had written a reply contradicting post #61 and deleted it. Here is what survived. The published rates come from populations that were titrated on a defined schedule…
Tracking that stops updating and then resumes — the long version Replied, post #60 · Sourcing › Logistics · 2 Jan 2026 · 11 likes Anyone deciding whether a delay is a problem should ask what would change if they waited another week. Usually the answer is nothing.
About the Other compounds category Replied, post #5 · Compounds › Other compounds · 19 Dec 2025 · 24 likes Colour in a lyophilised cake is worth noting for the less common compounds specifically, because some of them are genuinely not white and a member expecting white will…
Revisiting: Language barriers in accessing a prescription abroad Replied, post #10 · Access › International · 13 Dec 2025 · 0 likes I had written a reply contradicting post #6 and deleted it. Here is what survived. Regulatory position dates: a regulatory position is only current as of when it was…
Coverage in the US: a map of the usual obstacles Replied, post #21 · Regional › North America · 11 Dec 2025 · 5 likes Answering the question post #19 raises rather than the one it answers. Canada: Health Canada licenses compounds. Prescribing is provincial. Compounds are…
Reference intervals: how they are constructed and why one in twenty flags Replied, post #15 · Clinical › Bloodwork · 24 Nov 2025 · 0 likes I think the reference intervals question is answerable and has not been answered, which is a more optimistic position than most of this thread.
Specificity, linearity, accuracy, precision, range, robustness — with real criteria — a… Replied, post #42 · Analytics › Method validation · 24 Nov 2025 · 22 likes Limits of detection and quantitation: LOD is the lowest concentration that produces a signal above background. LOQ is the lowest concentration at which the method meets…
What a purity-only report leaves out Replied, post #101 · Sourcing › Independent verification · 24 Nov 2025 · 0 likes Post #97 describes the usual case. This is about the unusual one. Where the purity-only reasoning breaks down for me is the step from the group result to the individual…
Warfarin and altered intake: the monitoring argument — the long version Replied, post #53 · Practice › Interactions · 19 Nov 2025 · 9 likes On post #50 — agreed on the reasoning, with one qualification. Small correction to my own earlier position on Warfarin and altered intake. I had the units the wrong way…
Absolute versus relative contraindications Replied, post #6 · Safety › Contraindications · 19 Nov 2025 · 19 likes Gastroparesis or severe delayed gastric emptying: these compounds slow gastric emptying. Pre-existing severe gastroparesis can be worsened. That is a relative…
Severe gastroparesis and why this class is a poor fit — one year on Replied, post #6 · Safety › Contraindications · 16 Nov 2025 · 3 likes The reason Severe gastroparesis keeps being re-asked is that the answer is conditional and people quote it without the condition. It is not that the answer is unknown.
What a confidence interval means, from scratch — the long version Replied, post #17 · Research Methods › Statistics · 14 Nov 2025 · 10 likes Narrowing post #15, because the general version has more than one answer. Effect size with an interval is more informative than a significance verdict in essentially…
Oral versus injectable exposure: comparing apples to a different fruit Replied, post #10 · Compounds › Oral incretins · 10 Nov 2025 · 0 likes This follows post #7 rather than contradicting it. SNAC is the sodium N-(8-[2-hydroxybenzoyl]amino) caprylate, an absorption enhancer that transiently raises local pH…
Retatrutide's phase 2 heart-rate signal and how to think about it Replied, post #12 · Compounds › Retatrutide · 8 Nov 2025 · 32 likes Useful. I had the fact and not the reason, which turns out to be the important half.
Follow-up: Why appetite effects are mostly central Replied, post #82 · Pharmacology › Receptor biology · 31 Oct 2025 · 3 likes I would be cautious about generalising from the appetite effects example above. It is a good example. It is one example.
Amylin receptor signalling and satiety Replied, post #18 · Pharmacology › Receptor biology · 29 Oct 2025 · 3 likes Glucagon receptor agonism raises energy expenditure and promotes hepatic fat oxidation. In a triple agonist the incretin limbs offset the glycaemic consequence, which…
The anatomy of a question that gets answered within an hour — the long version Replied, post #30 · Start Here › How to Ask · 27 Oct 2025 · 29 likes If the answer you got does not fit your case, say which part does not fit rather than restating the question. Otherwise the next reply is the same as the last one. I…
Coming back to: Resolution and tailing factor: real acceptance criteria Replied, post #111 · Analytics › HPLC & UHPLC · 17 Oct 2025 · 1 like Area percent is not mass percent. It is a proportion of absorbance, weighted by each species' extinction coefficient. For closely related impurities the approximation…
Stepping down deliberately, and how to do it without losing progress Replied, post #4 · Practice › Dosing & titration · 14 Oct 2025 · 12 likes Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose.…
Where to report an adverse event officially, by region — a second dataset Replied, post #19 · Safety › Adverse events · 14 Oct 2025 · 0 likes Nothing to add, except that this is the answer I would give if asked.
A pen that felt like it delivered nothing: diagnosing it afterwards Replied, post #22 · Devices › Pens & autoinjectors · 7 Oct 2025 · 7 likes Comparing cost per milligram between a pen and a vial ignores wastage, dead volume and the number of doses actually obtainable. Cost per delivered dose at your dose is…
An orphaned page with no inbound links — the long version Started this topic · Meta › Wiki maintenance · 6 Oct 2025 · 37 likes Posting this under the heading it deserves: An orphaned page with no inbound links — the long version Everything below is what sits behind that. A narrow question about…
Documentation that materially improves an appeal's chances Replied, post #19 · Access › Insurance & coverage · 5 Oct 2025 · 2 likes That is the distinction I keep failing to hold on to. Written down now.
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #122 · Access › Insurance & coverage · 16 Sep 2025 · 24 likes Denial letters: the stated reason tells you exactly what to submit next. A denial is not final; it is a specification for an appeal. Reading the reason carefully and…
Coming back to: Over-dilution: when your dose falls below one readable graduation Replied, post #56 · Practice › Reconstitution · 16 Sep 2025 · 19 likes I read post #52 twice before replying, because I had assumed the opposite. Choosing a concentration on purpose rather than by accident: starting with "I want to draw…
Lipase elevation without symptoms: the interpretation problem Replied, post #8 · Clinical › Bloodwork · 14 Sep 2025 · 0 likes Building on post #5 rather than restating it. Repeat before acting is standard practice for an isolated abnormal result on most analytes, and it is standard for a…
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #114 · Data & Tools › Calculators · 12 Sep 2025 · 0 likes Post #111 answers the question as asked. The question underneath it is different. Titration planning: a calculator that shows you the escalation schedule for different…
Semaglutide versus liraglutide head to head: reading STEP 8 carefully Replied, post #55 · Compounds › Semaglutide · 8 Sep 2025 · 5 likes This is the answer, and the reason it is the answer is the more useful part.
Why oral semaglutide needs an absorption enhancer at all Replied, post #30 · Compounds › Oral incretins · 2 Sep 2025 · 16 likes Taking oral semaglutide seriously for a moment rather than deflecting: the honest position is that the community has observations and no controlled comparison, and…
How to read a phase 2 result without treating it as a phase 3 result — what changed since Replied, post #2 · Compounds › Retatrutide · 31 Aug 2025 · 4 likes How to read phase 2 without treating it as phase 3: phase 2 establishes that a dose range produces an effect and is tolerable enough to justify large trials. It does…
Request: show the solution author in the topic list Started this topic · Meta › Feature requests · 15 Aug 2025 · 3 likes Posting this under the heading it deserves: Request: show the solution author in the topic list Everything below is what sits behind that. Process question, and I have…
A request that was declined, and the reasoning — a second dataset Replied, post #85 · Documentation › Wiki requests · 14 Aug 2025 · 28 likes Documents that are mostly a worked example age better than documents that are mostly a summary, because the arithmetic does not change.
When a preprint is the best available evidence and we say so Replied, post #54 · Evidence › Preprints · 14 Aug 2025 · 0 likes Taking post #52 at face value and following it one step further. The honest position on most preprints in this field is that they are interesting and provisional, and…
The "under review" status pill and when a moderator applies it — a second dataset Replied, post #9 · Evidence › Preprints · 13 Aug 2025 · 0 likes The honest position on most preprints in this field is that they are interesting and provisional, and that saying both is not fence-sitting.
When a tidy document is a signal and when it is decoration — does this still hold? Replied, post #3 · Analytics › COA interpretation · 9 Aug 2025 · 7 likes Check the lot on the vial against the lot on the document before anything else. It is the cheapest check available and it is the one that catches the mismatches that…
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #60 · Compounds › Repair & healing peptides · 6 Jul 2025 · 0 likes The version of TB-500 and thymosin beta-4 that I was taught turned out to be a teaching simplification. Useful, and not true in the way I had assumed it was.
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #48 · Compounds › Semaglutide · 30 Jun 2025 · 0 likes Picking up post #47: that is the part I would want checked first. Counterpoint on Semaglutide half-life, offered without confidence: the same observation is consistent…
Repeatability versus intermediate precision Replied, post #33 · Analytics › Method validation · 21 Jun 2025 · 30 likes An observation about repeatability versus intermediate precision that I cannot explain and am posting anyway, on the principle that unexplained observations are more…
[2026 update] An appeal that failed, and what I would do differently Replied, post #51 · Access › Insurance & coverage · 10 Jun 2025 · 20 likes Nothing here is legal or medical advice, and appeal processes differ enough by jurisdiction and payer that specifics do not transfer. Not the answer, but possibly the…
The CagriSema phase 2 paper and what a fixed combination buys Replied, post #44 · Compounds › Cagrilintide & amylin analogues · 19 May 2025 · 1 like Where I part company with post #42, and it is a narrow parting. What I would tell a new member reading about cagrisema phase 2 paper for the first time: the confident…
Journal club: the CagriSema phase 2 combination paper — a second dataset Replied, post #5 · Evidence › Journal club · 15 May 2025 · 0 likes Suggest the next paper at the end of the session rather than by message afterwards. The room has just worked out what it wants to know next. Reading it again, the…
Why fasting instructions for oral semaglutide are not optional advice — does this still… Replied, post #30 · Compounds › Oral incretins · 11 May 2025 · 0 likes The practical argument for an oral is adherence, and the published adherence data is less flattering than the argument. Daily dosing with fasting requirements is not…
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #111 · Compounds › Semaglutide · 10 May 2025 · 10 likes The arithmetic in post #109 is right; the assumption feeding it is the part to check. The SELECT trial changed the positioning because it was the first cardiovascular…
Vagal afferents and the gut-brain pathway Replied, post #3 · Pharmacology › Receptor biology · 5 May 2025 · 0 likes Fair, and the limits you put on it are the part I will remember.
Water content on a certificate and why it changes the arithmetic Replied, post #12 · Analytics › COA interpretation · 4 May 2025 · 0 likes The distinction between release testing and characterisation is one industrial documents make and retail ones usually do not. It is the difference between "we tested…
Journal club: STEP 4 and what a withdrawal design can prove Replied, post #30 · Evidence › Journal club · 27 Apr 2025 · 0 likes Trying to state the STEP 4 position in a way that someone who disagrees would recognise as fair, because I do not think the version in this thread passes that test.
Talking to a therapist about this specifically — does this still hold? Replied, post #49 · Wellbeing › Mental health · 22 Apr 2025 · 0 likes Second this, and I would have said it less carefully.
Dizziness on standing: the ordinary explanation first Replied, post #2 · Nutrition & Training › Hydration & electrolytes · 21 Apr 2025 · 19 likes The opening post describes the usual case. This is about the unusual one. Nobody has said the unglamorous part of dizziness on standing yet, so: most of the variation…
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #95 · Compounds › Cagrilintide & amylin analogues · 9 Apr 2025 · 19 likes An observation about amylin analogue mechanism that I cannot explain and am posting anyway, on the principle that unexplained observations are more useful public than…
Adducts: sodium, potassium, and the peak you did not expect Replied, post #59 · Analytics › Mass spectrometry · 7 Apr 2025 · 10 likes Post #58 is the version of this I will quote in future. One addition. The honest summary of what a mass result buys you: it narrows the field of what the material could…
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #131 · Access › International · 29 Mar 2025 · 9 likes Post #130 answers the question as asked. The question underneath it is different. Reading this Cross-border purchase within thread as someone who came in with a fixed…
Follow-up: Tesamorelin has an approved indication — what that changes about the evidence Replied, post #32 · Compounds › Secretagogues & GH axis · 28 Mar 2025 · 21 likes Reconstitution volumes in this family are often small enough that dead volume in the syringe is a meaningful fraction of the dose. A fixed-needle insulin syringe is…
Why cagrilintide alone is discussed so much less than in combination Replied, post #46 · Compounds › Cagrilintide & amylin analogues · 27 Mar 2025 · 0 likes Taking post #43 at face value and following it one step further. Cagrilintide alone looks different depending on whether you are reading the primary literature or the…
Maintainer handover: how it works Replied, post #73 · Meta › Wiki maintenance · 18 Mar 2025 · 5 likes Post #69 put the caveat in the right place and I want to underline it. Review dates: each maintained page has a review date (the date by which it should be checked). If…
Cost per milligram, computed honestly across formats — the long version Replied, post #37 · Access › Pricing · 18 Mar 2025 · 0 likes Wastage from a concentration choice that leaves an unusable remainder is a real cost and is invisible in a per-milligram figure. I would be glad to be shown a cleaner…
Coverage for the indication versus for the drug — a second dataset Replied, post #19 · Access › Insurance & coverage · 15 Mar 2025 · 0 likes I read post #15 twice before replying, because I had assumed the opposite. An honest declaration on Coverage: I have a prior here and it is strong enough that you…
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #43 · Practice › Reconstitution · 28 Feb 2025 · 7 likes A vial that will not fully dissolve: check in order: is the diluent genuinely room temperature (some preservatives crystallise in cold), is the vial being warmed gently…
When "no data" is the complete and final answer Replied, post #101 · Compounds › Other compounds · 24 Feb 2025 · 0 likes Quietly grateful for the plain phrasing. Not every thread gets that.
Distinguishing a deletion sequence by mass alone Replied, post #111 · Analytics › Mass spectrometry · 20 Feb 2025 · 27 likes Tandem mass spectrometry with fragmentation gives sequence information that intact mass cannot. It is the analysis that would actually confirm identity, and it is…
Ipamorelin selectivity claims and where they came from Replied, post #13 · Compounds › Secretagogues & GH axis · 14 Feb 2025 · 0 likes Agreed on ipamorelin selectivity claims, with one qualification that I think matters. The reasoning holds for the case as described. Change the starting assumption and…
A supplier that answers analytical questions with restated claims Replied, post #20 · Sourcing › Red flags · 6 Feb 2025 · 17 likes That is the distinction I keep failing to hold on to. Written down now.
Feature request: should a dose-equivalence tool exist at all? Replied, post #21 · Data & Tools › Calculators · 29 Jan 2025 · 0 likes The most common input error is entering the vial mass in the concentration field. It produces a plausible number, which is why it survives.
Distinguishing a deletion sequence by mass alone Replied, post #10 · Analytics › Mass spectrometry · 22 Jan 2025 · 1 like Mass accuracy is expressed in parts per million. It is the difference between observed and theoretical mass divided by theoretical mass, multiplied by a million. A…
Follow-up: Individual participant data versus aggregate data Replied, post #82 · Evidence › Meta-analyses · 11 Jan 2025 · 22 likes Nothing to add on the substance. Thank you for taking the question at face value.
Washout with a one-week half-life: the arithmetic Replied, post #43 · Research Methods › N-of-1 designs · 30 Nov 2024 · 5 likes Coming back to post #41, because the follow-up matters more than the original answer. A definition problem is doing most of the work in this washout discussion. Once…
Why "any advice?" is the least effective ending for a post Replied, post #33 · Start Here › How to Ask · 13 Nov 2024 · 24 likes Confirming post #30 from a second method, which matters more than confirming it from a second person. It is fine to say you cannot explain why you are asking. Nobody…
Identical chromatograms across two different lots Replied, post #48 · Sourcing › Red flags · 11 Nov 2024 · 7 likes This follows post #47 rather than contradicting it. Keep the two claims separate. "The result on this lot did not match the certificate" is a report that can be…
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #97 · Compounds › Other compounds · 6 Nov 2024 · 7 likes Agreed on all of that, and I have nothing to add to it.
Requesting a page: what makes a good request — what changed since Started this topic · Documentation › Wiki requests · 8 Oct 2024 · 48 likes Posting this under the heading it deserves: Requesting a page: what makes a good request — what changed since Everything below is what sits behind that. What changes if…
Type 2 diabetes and the largest part of the evidence base — does this still hold? Replied, post #3 · Clinical › Comorbidities · 25 Sep 2024 · 1 like The bit of Type 2 diabetes that nobody enjoys is that the answer changes depending on what you are trying to decide with it. Say what the decision is and the thread…
Second pass at: Reimbursement variation across member states Replied, post #8 · Regional › European Union · 11 Sep 2024 · 21 likes On post #4 — agreed on the reasoning, with one qualification. An observation about Reimbursement variation across member states that I cannot explain and am posting…
Revisiting: A staff appointment, and what the role involves Started this topic · Meta › Announcements · 12 Aug 2024 · 1 like Revisiting: A staff appointment, and what the role involves — setting out what I have, and where I think it stops being reliable. Reading back through what has been…
Follow-up: A partial dose because the pen emptied mid-injection Replied, post #12 · Practice › Administration · 11 Aug 2024 · 11 likes Confirming post #10 from a second method, which matters more than confirming it from a second person. The single most common technique error described here is drawing…
Guidelines revision: what changed and why Replied, post #27 · Meta › Announcements · 25 Jul 2024 · 2 likes The claim about guidelines revision upthread is stronger than its source supports. I have read the source. The source says "associated with" and the post says "causes".
Blind submission and why it changes minds Replied, post #18 · Sourcing › Independent verification · 19 Jul 2024 · 23 likes Repeat testing: if you want to verify the same lot a second time, testing with a different service strengthens the conclusion. Testing with the same service verifies…
The mass-error checker and its intended scope Replied, post #132 · Data & Tools › Calculators · 18 Jul 2024 · 0 likes That is clearer than the version I had in my head. Thank you.
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #71 · Practice › Dosing & titration · 8 Jul 2024 · 31 likes Everything in post #67 holds. The case it does not cover is the one I have. The version of Splitting a weekly dose that circulates here is a simplification of a…